AstraZeneca PLC (AZN)
166.80
+0.82
(+0.49%)
USD |
NYSE |
Aug 24, 16:00
166.71
-0.09
(-0.05%)
After-Hours: 20:00
AstraZeneca Profit Margin (Quarterly) : 20.15% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 20.15% |
| December 31, 2025 | 15.02% |
| September 30, 2025 | 16.69% |
| June 30, 2025 | 16.93% |
| March 31, 2025 | 21.50% |
| December 31, 2024 | 10.07% |
| September 30, 2024 | 10.56% |
| June 30, 2024 | 14.90% |
| March 31, 2024 | 17.19% |
| December 31, 2023 | 7.98% |
| September 30, 2023 | 11.99% |
| June 30, 2023 | 15.94% |
| March 31, 2023 | 16.58% |
| December 31, 2022 | 8.05% |
| September 30, 2022 | 14.95% |
| June 30, 2022 | 3.34% |
| March 31, 2022 | 3.41% |
| December 31, 2021 | -2.86% |
| September 30, 2021 | -16.73% |
| June 30, 2021 | 6.69% |
| March 31, 2021 | 18.58% |
| December 31, 2020 | 12.69% |
| September 30, 2020 | 9.65% |
| June 30, 2020 | 11.67% |
| March 31, 2020 | 11.19% |
| Date | Value |
|---|---|
| December 31, 2019 | 3.92% |
| September 30, 2019 | 4.21% |
| June 30, 2019 | 1.84% |
| March 31, 2019 | 9.37% |
| December 31, 2018 | 13.92% |
| September 30, 2018 | 7.09% |
| June 30, 2018 | 5.61% |
| March 31, 2018 | 6.10% |
| December 31, 2017 | 21.83% |
| September 30, 2017 | 10.41% |
| June 30, 2017 | 8.83% |
| March 31, 2017 | 9.47% |
| December 31, 2016 | 32.53% |
| September 30, 2016 | 17.46% |
| June 30, 2016 | -0.55% |
| March 31, 2016 | 10.22% |
| December 31, 2015 | 12.63% |
| September 30, 2015 | 12.95% |
| June 30, 2015 | 11.04% |
| March 31, 2015 | 9.11% |
| December 31, 2014 | -4.78% |
| September 30, 2014 | 3.83% |
| June 30, 2014 | 11.79% |
| March 31, 2014 | 7.83% |
| December 31, 2013 | -7.60% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| GSK Plc | 6.58% |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
| Merck & Co., Inc. | -8.06% |
| Novo Nordisk A/S | 26.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 22.80% |
| Return on Assets | 9.26% |
| Return on Invested Capital | 13.38% |
| Gross Profit Margin (Quarterly) | 76.09% |
| Operating Margin (Quarterly) | 26.93% |
| Return on Net Operating Assets | 11.21% |